Document ID: chunk:federal_register_of_legislation:F2019L01096:reg:9:p1
Version: federal_register_of_legislation:F2019L01096
Segment Type: reg
Provision Reference: reg 9 (pt 1/4)
Character Range: 4014–7052

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the bladder or death from malignant neoplasm of the bladder with the circumstances of a person's relevant service:
(1)          smoking at least 2.5 pack-years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of malignant neoplasm of the bladder, where smoking commenced at least five years before the clinical onset of malignant neoplasm of the bladder;
            Note: pack-years of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 – Dictionary.
(2)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the bladder at least five years before the clinical onset of malignant neoplasm of the bladder;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(3)          inhaling, ingesting or having cutaneous contact with high concentrations of polycyclic aromatic hydrocarbons, through work involving the specified industrial or manufacturing process 1:
(a)          for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the bladder; and
(b)          where the first exposure occurred at least five years before the clinical onset of malignant neoplasm of the bladder;
            Note: polycyclic aromatic hydrocarbons and specified industrial or manufacturing process 1 are defined in the Schedule 1 - Dictionary.
(4)          inhaling, ingesting or having cutaneous contact with an agent from the specified list of agents containing high concentrations of polycyclic aromatic hydrocarbons:
(a)          for a cumulative period of at least 1 500 hours before the clinical onset of malignant neoplasm of the bladder; and
(b)          where the first exposure occurred at least five years before the clinical onset of malignant neoplasm of the bladder;
            Note: specified list of agents containing high concentrations of polycyclic aromatic hydrocarbons is defined in the Schedule 1 – Dictionary.
(5)          inhaling, ingesting or having cutaneous contact with an aromatic amine from the specified list of aromatic amines:
(a)          for a cumulative period of at least 1 000 hours, before the clinical onset of malignant neoplasm of the bladder; and
(b)          where the first exposure occurred at least five years before the clinical onset of malignant neoplasm of the bladder;
            Note 1: Inhaling, ingesting or having cutaneous contact with an aromatic amine does not include exposure due to cigarette smoke or hair dyes.

            Note 2: specified list of aromatic amines is defined in the Schedule 1 – Dictionary.
(6)          inhaling, ingesting or having cutaneous contact with a high concentration of an aromatic amine, through work involving the specified industrial or manufacturing process